Cancer Institute A national cancer institute
designated cancer center

What is Cutaneous Lymphoma

Microscopic Image of abnormal lymphocytesMicroscopic Image of abnormal lymphocytes

Cutaneous lymphomas comprise a rare group of Non-Hodgkins lymphoma that arise primarily in the skin.
The Stanford Cutaneous Lymphoma Program is expert in the treatment and investigation of all forms of cutaneous lymphoma, including the relatively more common T-cell and B-cell cutaneous lymphomas.

The most common type of cutaneous T-cell lymphoma is mycosis fungoides and its leukemic variant, Sezary syndrome. The other more commonly seen forms of cutaneous lymphoma include the CD30 positive lymphoproliferative disorders (CD30+ LPDs). Whereas primary cutaneous anaplastic large cell lymphoma (pcALCL) is a malignant CD30+ LPD, the benign spectrum of the CD30+ LPDs includes lymphomatoid papulosis. We are expert in the diagnosis, treatment, and investigation of these and other forms of cutaneous T-cell lymphoma.
We are also expert in the diagnosis, treatment, and investigation of cutaneous B-cell lymphomas, including primary cutaneous marginal zone lymphoma, primary cutaneous follicle center cell lymphoma, and primary cutaneous diffuse large B-cell lymphoma (including leg-type).

Stanford Medicine Resources:

Footer Links: